Clinical Trials Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12 Jan 2021
Total number of Covid-19 clinical trials continues to rise as cases and deaths rise 22nd January 2021
Big Pharma is forging an increased number of partnerships with artificial intelligence vendors for drug discovery services 22nd January 2021
Could Moderna and BioNTech’s Covid-19 vaccines pave the way for mRNA-based cancer vaccines? 21st January 2021
ASCO-GI 2021: Agios will file for a new Tibsovo label in 2L cholangiocarcinoma despite an OS advantage setback 20th January 2021
REMD-477 topline results highlight the benefits of adjunct therapies in type 1 diabetes 19th January 2021
Preliminary results from Aldeyra’s Phase III TRANQUILITY trial offer promise for patients with dry eye syndrome 18th January 2021
Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12th January 2021
Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market On January 7, Teva Pharmaceuticals and MedinCell announced positive results from their Phase III trial... 11th January 2021
Prevention of thrombosis in Covid-19 patients: Only a small number of ongoing US Trials investigating NOACs in the outpatient setting 4th January 2021
Clinical Research Reify Health extends StudyTeam platform availability for clinical trials 21 Jan 2021